PCH
MDGL icon

Polar Capital Holdings’s Madrigal Pharmaceuticals MDGL Stock Holding History

Polar Capital Holdings’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$151M Buy
289,310
+19,159
+7% +$9.15M 0.66% 46
2025
Q4 		$157M Buy
270,151
+4,997
+2% +$2.55M 0.72% 46
2025
Q3 		$122M Buy
265,154
+39,744
+18% +$14.8M 0.59% 52
2025
Q2 		$68.2M Buy
225,410
+75,190
+50% +$22.4M 0.36% 73
2025
Q1 		$49.8M Buy
150,220
+12,500
+9% +$4.11M 0.3% 95
2024
Q4 		$42.5M Buy
137,720
+37,245
+37% +$10.5M 0.24% 105
2024
Q3 		$21.3M Sell
100,475
-24,825
-20% -$6.35M 0.1% 141
2024
Q2 		$35.1M Buy
125,300
+95
+0.1% +$22.6K 0.21% 104
2024
Q1 		$33.4M Buy
+125,205
New +$29.5M 0.18% 109

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return